Published in TB and Outbreaks Week, November 26th, 2002
"Munumbicins A, B, C and D are newly described antibiotics with a wide spectrum of activity against many human as well as plant pathogenic fungi and bacteria, and a Plasmodium sp.," explained Uvidelio F. Castillo and colleagues working at Montana State University in Bozeman, Brigham Young University in Provo, Utah, Harvard Medical School in Boston, the University of Washington in Seattle, and Veterans Affairs Medical Center in Boise, Idaho. "These compounds were obtained from Streptomyces NRRL 3052,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.